Erytech Pharma S.A. buy tbackenh
Start price
31.03.17
/
50%
€28.20
Target price
02.10.17
€32.00
Performance (%)
-17.59%
End price
02.10.17
€23.24
Summary
This prediction ended on 02.10.17 with a price of €23.24. The price of Erytech Pharma S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.59%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% | 53.022% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% | 95.411% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% | 54.646% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% | 66.550% |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€19.25
26.09.16
26.09.16
€22.00
27.03.17
27.03.17
-25.71%
27.03.17
27.03.17
